Sonoma Pharmaceuticals (SNOA) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Sonoma Pharmaceuticals Revenue Highlights


Latest Revenue (Y)

$12.73M

Latest Revenue (Q)

$3.44M

Main Segment (Y)

Human Care

Main Geography (Y)

Service

Sonoma Pharmaceuticals Revenue by Period


Sonoma Pharmaceuticals Revenue by Year

DateRevenueChange
2024-03-31$12.73M-4.05%
2023-03-31$13.27M5.10%
2022-03-31$12.63M-32.21%
2021-03-31$18.63M-1.62%
2020-03-31$18.94M-0.18%
2019-03-31$18.97M13.88%
2018-03-31$16.66M29.89%
2017-03-31$12.82M-14.98%
2016-03-31$15.08M8.88%
2015-03-31$13.85M1.36%
2014-03-31$13.67M-11.55%
2013-03-31$15.45M21.25%
2012-03-31$12.74M30.65%
2011-03-31$9.75M32.46%
2010-03-31$7.36M36.67%
2009-03-31$5.39M40.50%
2008-03-31$3.83M-15.58%
2007-03-31$4.54M75.81%
2006-03-31$2.58M90.56%
2005-03-31$1.36M50.33%
2004-03-31$902.00K-63.48%
2003-03-31$2.47M23.50%
2002-03-31$2.00M-

Sonoma Pharmaceuticals generated $12.73M in revenue during NA 2024, up -4.05% compared to the previous quarter, and up 67.13% compared to the same period a year ago.

Sonoma Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-03-31$3.44M9.59%
2023-12-31$3.14M14.90%
2023-09-30$2.73M-20.31%
2023-06-30$3.43M13.70%
2023-03-31$3.01M2.38%
2022-12-31$2.94M-11.62%
2022-09-30$3.33M-16.37%
2022-06-30$3.98M73.32%
2022-03-31$2.30M-20.81%
2021-12-31$2.90M-22.49%
2021-09-30$3.74M1.63%
2021-06-30$3.68M70.79%
2021-03-31$2.16M-56.30%
2020-12-31$4.94M-14.44%
2020-09-30$5.77M-20.47%
2020-06-30$7.25M58.42%
2020-03-31$4.58M-2.12%
2019-12-31$4.68M-5.84%
2019-09-30$4.97M5.46%
2019-06-30$4.71M7.51%
2019-03-31$4.38M-17.01%
2018-12-31$5.28M6.90%
2018-09-30$4.94M13.05%
2018-06-30$4.37M19.53%
2018-03-31$3.65M-24.53%
2017-12-31$4.84M11.98%
2017-09-30$4.33M12.78%
2017-06-30$3.83M-4.82%
2017-03-31$4.03M19.88%
2016-12-31$3.36M-18.18%
2016-09-30$4.11M7.79%
2016-06-30$3.81M7.96%
2016-03-31$3.53M-7.59%
2015-12-31$3.82M-5.77%
2015-09-30$4.05M10.16%
2015-06-30$3.68M-7.54%
2015-03-31$3.98M23.68%
2014-12-31$3.22M-1.41%
2014-09-30$3.26M-3.77%
2014-06-30$3.39M16.40%
2014-03-31$2.91M-11.51%
2013-12-31$3.29M-19.47%
2013-09-30$4.09M21.26%
2013-06-30$3.37M1.11%
2013-03-31$3.33M-5.79%
2012-12-31$3.54M-21.79%
2012-09-30$4.53M11.73%
2012-06-30$4.05M20.89%
2012-03-31$3.35M20.11%
2011-12-31$2.79M-23.83%
2011-09-30$3.66M24.59%
2011-06-30$2.94M8.45%
2011-03-31$2.71M17.21%
2010-12-31$2.31M-6.20%
2010-09-30$2.47M8.92%
2010-06-30$2.26M1.43%
2010-03-31$2.23M38.38%
2009-12-31$1.61M-3.53%
2009-09-30$1.67M-9.47%
2009-06-30$1.85M25.22%
2009-03-31$1.48M20.80%
2008-12-31$1.22M-17.56%
2008-09-30$1.48M22.30%
2008-06-30$1.21M30.78%
2008-03-31$926.00K-13.13%
2007-12-31$1.07M-

Sonoma Pharmaceuticals generated $3.44M in revenue during Q4 2024, up 9.59% compared to the previous quarter, and up 116.81% compared to the same period a year ago.

Sonoma Pharmaceuticals Revenue Breakdown


Sonoma Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMar 24Mar 23Mar 22Mar 21Mar 20
Service And Royalty$422.00K----
Animal Care$2.20M----
Human Care$10.11M----
Shipping and Handling-$42.00K$52.00K$37.00K-
Service--$349.00K$112.00K-
Product----$15.69M

Sonoma Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Mar 24: Human Care (79.39%), Animal Care (17.30%), and Service And Royalty (3.31%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Dec 20Sep 20Jun 20Mar 20Mar 19
Animal Care$1.09M$621.00K$489.00K$414.00K$818.00K$1.00M$812.00K$1.36M$951.00K$377.00K------
Human Care$5.57M$2.46M$2.08M$1.81M$2.02M$2.59M$2.71M$3.53M$4.78M$6.86M------
Service And Royalty$199.00K$56.00K$167.00K$69.00K$148.00K$157.00K----------
Service---$99.00K$75.00K$147.00K$1.03M$280.00K--------
Other Sales-----------$45.00K$42.00K$13.00K--
Product---------------$4.11M

Sonoma Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Human Care (81.18%), Animal Care (15.92%), and Service And Royalty (2.90%).

Sonoma Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryMar 22
Shipping and Handling$52.00K
Service$349.00K

Sonoma Pharmaceuticals's latest annual revenue breakdown by geography, as of Mar 22: Service (87.03%), and Shipping and Handling (12.97%).

Quarterly Revenue by Country

CountryDec 20Sep 20Jun 20
Europe and Rest of the World$1.65M$1.76M$3.21M
UNITED STATES$1.98M$1.98M$1.72M
Latin America$1.31M$2.02M$2.32M

Sonoma Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Dec 20: UNITED STATES (40.07%), Europe and Rest of the World (33.45%), and Latin America (26.48%).

Sonoma Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.39M
LFCRLifecore Biomedical$128.26M$24.70M
ACORAcorda Therapeutics$102.42M$20.29M
ALIMAlimera Sciences$80.75M$23.01M
DERMJourney Medical$79.18M$14.86M
SBFMSunshine Biopharma$39.85M$9.30M
TKNOAlpha Teknova$36.68M$9.61M
UPCUniverse Pharmaceuticals$32.31M$13.84M
SNOASonoma Pharmaceuticals$12.73M$3.44M
GHSIGuardion Health Sciences$12.25M$36.35K
AKANAkanda$2.16M$762.61K
SXTCChina SXT Pharmaceuticals$1.97M$939.58K
SHPHShuttle Pharmaceuticals--

SNOA Revenue FAQ


Sonoma Pharmaceuticals's yearly revenue for 2024 was $12.74M, representing a decrease of -4.05% compared to 2023. The company's yearly revenue for 2023 was $13.27M, representing an increase of 5.10% compared to 2022. SNOA's yearly revenue for 2022 was $12.63M, representing a decrease of -32.21% compared to 2021.

Sonoma Pharmaceuticals's quarterly revenue for Q4 2024 was $3.44M, a 9.59% increase from the previous quarter (Q3 2024), and a 14.10% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $3.14M, a 14.90% increase from the previous quarter (Q2 2024), and a 6.59% increase year-over-year (Q3 2023). SNOA's quarterly revenue for Q2 2024 was $2.73M, a -20.31% decrease from the previous quarter (Q1 2024), and a -18.01% decrease year-over-year (Q2 2023).

Sonoma Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0.85%, and for the last 5 years (2020-2024) was -32.75%.

Sonoma Pharmaceuticals's revenue streams in r 24 are Service And Royalty, Animal Care, and Human Care. Service And Royalty generated $422K in revenue, accounting 3.31% of the company's total revenue Animal Care generated $2.2M in revenue, accounting 17.30% of the company's total revenue Human Care generated $10.11M in revenue, accounting 79.39% of the company's total revenue

For the fiscal year ending Mar 24, the largest source of revenue of Sonoma Pharmaceuticals was Human Care. This segment made a revenue of $10.11M, representing 79.39% of the company's total revenue.